Cargando…
PTEN regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
PTEN loss, one of the most frequent mutations in prostate cancer (PC), is presumed to drive disease progression through AKT activation. However, two transgenic PC models with Akt activation plus Rb loss exhibited different metastasis development: Pten/Rb(PE:−/−) mice produced systemic metastatic ade...
Autores principales: | Miller, Karina, Degan, Seamus, Wang, Yanqing, Cohen, Joseph, Ku, Sheng-Yu, Goodrich, David, Gelman, Irwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246239/ https://www.ncbi.nlm.nih.gov/pubmed/37292818 http://dx.doi.org/10.21203/rs.3.rs-2924750/v1 |
Ejemplares similares
-
Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
por: Berenjeno, Inma M., et al.
Publicado: (2012) -
Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas
por: Xie, Shaozhen, et al.
Publicado: (2020) -
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011) -
PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition
por: Zhao, Hua-Fu, et al.
Publicado: (2016) -
Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
por: Soler, Adriana, et al.
Publicado: (2013)